|
Anakinra 100 mg/day (194 total days)
|
|
Serious events
|
|
Hospitalized to rule out thrombus
|
1
|
0.5
|
|
Non-serious events
|
|
Injection site reaction
|
3
|
1.5
|
|
Oral thrush
|
1
|
0.5
|
|
Other
|
2
|
1.0
|
|
Anakinra 200 mg/day (1371 total days)
|
|
Serious events
|
|
Pulmonary artery hypertension
|
1
|
0.1
|
|
Pre-syncope
|
1
|
0.1
|
|
Non-cardiac chest pain
|
1
|
0.1
|
|
Non-serious events
|
|
Upper respiratory infection
|
5
|
0.4
|
|
Alopecia
|
2
|
0.2
|
|
Edema
|
2
|
0.2
|
|
Vaginal yeast infection
|
1
|
0.1
|
|
Other
|
9
|
0.7
|
|
Anakinra 300 mg/day (322 total days)
|
|
Serious events
|
|
• None
|
0
|
0
|
|
Non-serious events
|
|
• Upper respiratory infection
|
2
|
0.6
|
|
• Vaginal yeast infection
|
1
|
0.3
|
|
• Other
|
2
|
0.6
|
